Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prometheus Biosciences Inc (NQ: RXDX )

107.78 +0.44 (+0.41%)
Streaming Delayed Price Updated: 9:32 AM EST, Feb 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,144
Open 107.88
Bid (Size) 106.64 (2)
Ask (Size) 108.92 (5)
Prev. Close 107.34
Today's Range 107.78 - 107.88
52wk Range 21.50 - 122.75
Shares Outstanding 41,700,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Expectations for Prometheus Biosciences's Future
 
Via Benzinga
How Is The Market Feeling About Prometheus Biosciences?
Prometheus Biosciences's (NASDAQ:RXDX) short percent of float has fallen 35.76% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 8.3% of all... 
Via Benzinga

Performance

YTD
+1.11%
+1.11%
1 Month
-0.54%
-0.54%
3 Month
+129.08%
+129.08%
6 Month
+116.95%
+116.95%
1 Year
+182.07%
+182.07%

More News

Read More
Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Prometheus Biosciences
Via Globe NewsWire
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
Via Benzinga
Looking Into Prometheus Biosciences's Return On Capital Employed
Via Benzinga
Where Prometheus Biosciences Stands With Analysts
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
Via Benzinga
Why Prometheus Biosciences Stock Is Falling
Via Benzinga
Is Prometheus Biosciences a Good Stock to Buy Right Now?
Via The Motley Fool
Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock
From Prometheus Biosciences
Via Globe NewsWire
Why Prometheus Biosciences Stock Is Rocketing Higher Today
Via Benzinga
Analyzing Prometheus Biosciences's Short Interest
Via Benzinga
Why Shares of Prometheus Biosciences Are Soaring This Week
Via The Motley Fool
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
Via Benzinga
Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock
From Prometheus Biosciences
Via Globe NewsWire
Dow Edges Higher; Prometheus Biosciences Shares Jump
Via Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Prometheus Biosciences (NASDAQ: RXDX) Reports PRA023 Candidate Achieved Positive Results in Both its ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Clinical Trials
Via Spotlight Growth
Nasdaq Drops 75 Points; Crude Oil Down 2%
Via Benzinga
Dow Bounces Back From Morning Selloff
Via Talk Markets
PINS Stock Alert: What to Know as Pinterest and Elliott Strike a Deal
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.